NewsBenzingaUCB ottiene l’approvazione FDA con il primo autoiniettore giornaliero del suo genere per una rara malattia muscolare UCB ottiene l’approvazione FDA con il primo autoiniettore giornaliero del suo genere per una rara malattia muscolare Benzinga 2026.10.16 14:53 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Commercial Metals, Lowers Price Target to $63 Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37 If You Invested $100 In Cenovus Energy Stock 5 Years Ago, You Would Have This Much Today Wells Fargo Maintains Overweight on Cleveland-Cliffs, Raises Price Target to $18 TD Cowen Maintains Buy on BWX Technologies, Lowers Price Target to $180